🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

First site (Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy) initiated for EAU RF Pegasus study (Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery)#andreanecchi #trialPegasus

First patient enrolled for #VENUSRegistry (AUS Surgery for Female SUI due to ISD) at the Hospital Ramón y Cajal in Madrid, Spain. We congratulate Dr. Luis López-Fando Lavalle and his team members!

Happy to announce that the very 1st patient has been included in the VENUS study, the 1st international prospective multicenter study on artificial urinary sphincter implantation in female patients. Congrats to Luis Lopez-Fando 🇪🇸& its team! EAUrf #NCT04114266

150 patients enrolled at the UZ Leuven for #SATURNRegistry (Surgery for Male Stress Urinary Incontinence). We congratulate Prof. Frank Van der Aa and his team members!

Results from the #NIMBUSstudy (reduced frequency BCG instillations in NMIBC) presented at Game Changing Session 2 #EAU20 Saturday 18 July 8.30.

Update on #SATURNRegistry (Surgery for Male Stress Urinary Incontinence) presented by Prof. Frank Van der Aa at #EAU20. See webcast/poster at Poster Session: The iatrogenic blues of male stress incontinence, are we out of the dark ages? Abstract 269.

EUPROMS study: "Initial treatment is often followed by subsequent treatments, affecting mainly sexual function, as well as fatigue and insomnia." #EarlyDetection and AS are the best ways to preserve the QoL of those affected by #ProstateCancer. 👇 sciencedirect.com/science/articl…

750th patient enrolled for #SATURNRegistry (Surgery for Male Stress Urinary Incontinence) at Guy’s Hospital, London, UK

Seeking funding for your exploratory research? The EAUrf’s seeding grants of up to € 25,000 allow young investigators with ideas for highly innovative research to start working on their projects. Deadline for applications: 31 March. Full details👇 uroweb.org/eau-rf-seeding…

Good news! Dr. Koen van Renterghem from Hasselt, Belgium, has enrolled the first two patients in the Phoenix registry. Congratulations Koen! We are off to a good start, with hopefully many more patients to come. Kind regards, On behalf of the Phoenix team

Target of 1000 patients reached in #SATURNRegistry (Surgery for Male Stress Urinary Incontinence)! Congrats to all particpating investigators and staff members. Thank you all for making this registry a great success!

We are happy to announce that study recruitment is over halfway mark of 75 patients! #VENUSRegistry (AUS Surgery for Female SUI due to ISD)

We are delighted to announce that we have reached another Milestone: 100 patients included! #VENUSRegistry (AUS Surgery for Female SUI due to ISD) Congratulations to all participating study members, this would not be possible without you!

#venus study investigator meeting with an all star steam🤩Luis Lopez-Fando chartier-kastler e corona.walrus Frank Van der Aa EAUrf So excited to learn that we should hit the target of 150 patients recruited before the end of the year #eau23@jncorny

Fantastic presentation by Alexander Ng at #EAU23 on the PRIME Study ⭐️ ✅ Background to PRIME ⚡️ ✅ Recruitment over the past year 🏃🏽 ✅ Implications of PRIME 🧠 European Association of Urology (EAU) European Society of Residents in Urology EAU Young Academics EAUrf EAU Young Urologists #UroSoMe

#Phoenix milestone: 500 patients recruited. We are halfway there! Congratulations to all who have contributed. Keep up the good work.

VENUS: Prospective Registry for Patients Undergoing AUS Surgery for Female SUI due to ISD 🎉 We are thrilled to announce we have reached full inclusion for the VENUS registry! 🙌Congratulations to all participating investigators for your invaluable contributions. #EAURF #VENUS

OLIGOMET: Outcomes of local treatment for oligometastatic prostate cancer diagnosed using PSMA PET imaging: OLIGOMET study 📢 Exciting news! The database for the OLIGOMET study is now LIVE. Inclusion has officially started! #OLIGOMET #StudyLaunch #EAURF

Thrilled to announce that we’ve reached full recruitment for the OPTILUME registry (Urethral Drug Coated Balloon)! 🙌 A big thank you to everyone who made this possible. Onward to the next phase! #OPTILUME #EAURF

Milestone achieved: Over 1,000 patients recruited, marking full recruitment for the PHOENIX registry! 🎉Thank you to everyone who contributed to this success. On to the next chapter! #PHOENIX #EAURF